A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial

Ebola viruses represent a class of filoviruses that causes severe hemorrhagic fever with high mortality. Recognized first in 1976 in the Democratic Republic of Congo, outbreaks continue to occur in equatorial Africa. A safe and effective Ebola virus vaccine is needed because of its continued emergen...

詳細記述

保存先:
書誌詳細
主要な著者: Martin, Julie E., Sullivan, Nancy J., Enama, Mary E., Gordon, Ingelise J., Roederer, Mario, Koup, Richard A., Bailer, Robert T., Chakrabarti, Bimal K., Bailey, Michael A., Gomez, Phillip L., Andrews, Charla A., Moodie, Zoe, Gu, Lin, Stein, Judith A., Nabel, Gary J., Graham, Barney S.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2006
主題:
Vaccine Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1656552/
https://ncbi.nlm.nih.gov/pubmed/16988008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00162-06
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料